Stockscreener 앱 받기
0.1884
1.10%
-0.0021
전일 마감가:
$0.1905
열려 있는:
$0.185
하루 거래량:
366.34K
Relative Volume:
0.15
시가총액:
$5.87M
수익:
$38,000
순이익/손실:
$-51.55M
주가수익비율:
-0.0981
EPS:
-1.9207
순현금흐름:
$-37.07M
1주 성능:
-16.23%
1개월 성능:
-44.26%
6개월 성능:
-81.35%
1년 성능:
-90.58%
1일 변동 폭
$0.1701
$0.1888
1주일 범위
$0.1701
$0.2342
52주 변동 폭
$0.1701
$2.88
센티 바이오사이언시스 Stock (SNTI) Company Profile
명칭
Senti Biosciences Holdings Inc
전화
(650) 239-2030
주소
2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO
Compare SNTI vs VRTX, REGN, MRNA, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNTI
Senti Biosciences Holdings Inc
|
0.1884 | 5.87M | 38,000 | -51.55M | -37.07M | -1.9207 |
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
센티 바이오사이언시스 Stock (SNTI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-14 | 개시 | H.C. Wainwright | Buy |
| 2025-06-06 | 개시 | Laidlaw | Buy |
| 2022-10-07 | 개시 | Morgan Stanley | Equal-Weight |
센티 바이오사이언시스 주식(SNTI)의 최신 뉴스
Senti Biosciences registers resale of 2.55 crore shares from notes - scanx.trade
Form 4 Senti Biosciences Holdings Inc For: 24 September By Investing.com - Investing.com India
Form 4 Senti Biosciences Holdings Inc For: 24 September By Investing.com - Investing.com UK
No cash at closing for Senti Biosciences (NASDAQ: SNTI) shareholders; future payments hinge on milestones. - Stock Titan
No cash at closing in Senti Biosciences (NASDAQ: SNTI)'s proposed merger; payments depend on milestones. - Stock Titan
Senti Biosciences (SNTI) refreshes auditor sign-off on shelf registration - Stock Titan
Senti Biosciences (NASDAQ: SNTI) Secures $2.5 Million Stock Purchase at Nasdaq Minimum Price Following Merger - Kalkine Media
Major backer lines up $2.5M for Senti Biosciences (NASDAQ: SNTI) if merger closes - Stock Titan
Convertible notes could hand one investor control of Senti (NASDAQ: SNTI) - Stock Titan
Senti Biosciences Holds Near $0.34 as SNTI Tests Key Support ZoneStrong Buy Stocks - dars.gov.et
Senti Biosciences Secures Equity Commitment Amid Merger Plans - TipRanks
Senti Biosciences Adds $2 Million Convertible Debt, $2.5 Million Equity Commitment Ahead of Merger - TradingView
Senti Biosciences Holdings, Inc.Common Stock (Nasdaq:SNTI) Stock Quote - The Chronicle-Journal
Senti Biosciences unit issues USD 2 million senior secured convertible notes to NSG BioInnovation Fund - Bitget
Senti Biosciences Inc (NASDAQ: SNTI) Share Price, SNTI Stock News, SNTI Share Price & Updates - Kalkine
Senti Biosciences amends securities agreement, adds note tranche - TipRanks
Senti Biosciences Holdings Received Notice of Noncompliance - TradingView
SNTI Q2'26 Earnings: EPS estimate is (0.27) USD - TradingView
Senti Biosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Senti Biosciences (SNTI) Gains 2.35% as Shares Hold Above Key Support at $0.36Risk Reward Setups - vinanet.vn
Senti Biosciences (SNTI) Gains 2.35% as Shares Hold Above Key Support at $0.36Triple Bottom - dars.gov.et
Senti Biosciences (NASDAQ:SNTI) to spin off SENTI-202 pipeline to Celadon-backed NewCo via CVRs - Kalkine
SNTI|Senti Biosciences Inc|Price:0.373|Chg%:-0.030 - TradingKey
$Senti Biosciences (SNTI.US)$ - Moomoo
Senti Biosciences Holdings, Inc. SEC Filing (Jul 21, 2026) - Stock Titan
Senti Biosciences (SNTI) Hovers Near Support as Stock Consolidates Below $0.45ETF Outflow Streak - vinanet.vn
Form 13D/A Senti Biosciences Holdings For: 16 July By Investing.com - Investing.com Nigeria
Form S-3/A Senti Biosciences Holdings Inc For: 16 July - Investing.com Nigeria
Form S-3/A Senti Biosciences Holdings Inc For: 16 July By Investing.com - Investing.com South Africa
Form 13D/A Senti Biosciences Holdings For: 16 July By Investing.com - Investing.com Canada
Senti Biosciences (SNTI) backer plans merger and $6M funding - Stock Titan
Form S-3/A Senti Biosciences Holdings Inc For: 16 July - Investing.com Canada
Senti Biosciences to spin off gene therapy unit for CVR - Investing.com
Senti Biosciences Holdings Announces Strategic Spin-Off of Gene-Circuit Pipeline and Plans Focus on Regulator Dial Platform - Quiver Quantitative
Senti Biosciences to Divest Operating Business to Celadon Affiliate; Holders Get Up to $60M CVRs - TradingView
Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline, Including SENTI-202, and to Sharpen its Focus on Next-Generation Controllable Genetic Medicines Powered by its Regulator Dial™ Te - Yahoo Finance
Price to sales forward of Senti Biosciences Holdings, Inc. – NASDAQ:SNTI - TradingView
Price to book forward of Senti Biosciences Holdings, Inc. – NASDAQ:SNTI - TradingView
Enterprise value to EBITDA forward of Senti Biosciences Holdings, Inc. – NASDAQ:SNTI - TradingView
Enterprise value to EBIT forward of Senti Biosciences Holdings, Inc. – NASDAQ:SNTI - TradingView
Senti Biosciences Holdings Inc Actuals & Estimates (NASDAQ:SNTI) - TradingView
Senti Biosciences Holdings Inc Actuals & Estimates (NASDAQ:SNTI) - TradingView
SNTI Forecast — Price Target — Prediction for 2027 - TradingView
SNTI Q1 2026 Earnings: Narrower Loss Surprises Amid Pre-Revenue StageGuidance Accuracy Score - dars.gov.et
Senti Biosciences (SNTI) registers 15.97M shares tied to May 2026 notes - Stock Titan
Senti Biosciences Inc (SNTI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SNTI Q1 2026 Earnings: Modest EPS Beat Amid Development ProgressEarnings Call Transcript - dars.gov.et
Senti Biosciences Inc (SNTI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
The Radoff-JEC Group Highlights Seer Inc.’s and Chairman and CEO Omid Farokhzad, M.D.’s History of Value Destruction - Business Wire
SNTISenti Biosciences Holdings Inc Options - Finviz
센티 바이오사이언시스 (SNTI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.09%
0.72%
자본화:
|
볼륨(24시간):